Anmy Vu, DPM
Podiatrist · Las Vegas, NVNPI 1285122135
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Goode Surgical Inc at 43.6% of the total. Reporting peaked in 2022 at $7,536 and has fallen 83.7% since, to $1,231 in 2025.
Across 68 payments — averaging $222.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Goode Surgical Inc$7K
- Arthrex$4K
- Trilliant Surgical LLC.$1K
- Stryker$1K
- Paragon 28, Inc.$1K
- Treace Medical Concepts, Inc.$595
- plus $503 from 5 others
What the payments were for
- Travel & lodging$3,79925%
- Food & beverage$2,90619%
- Education$8,40056%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Goode Surgical Inc | 16 | $6,588 |
| Arthrex | 17 | $3,880 |
| Trilliant Surgical LLC. | 4 | $1,468 |
| Stryker | 12 | $1,067 |
| Paragon 28, Inc. | 5 | $1,003 |
| Treace Medical Concepts, Inc. | 7 | $595 |
| Biotissue Holdings Inc. | 2 | $250 |
| Smith+Nephew | 2 | $152 |
| Cook Medical LLC | 1 | $60 |
| Bioventus LLC | 1 | $24 |
| Convatec Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Arsenal Sinus Support Plate$1,468
- PROstep$528
- Portfolio$420
- Phantom Fibula Nail$409
- Lapiplasty System$278
- NEOX$250
- CLARIX$250
- ORTHOLOC 2 LAPIFUSE$157
- AUGMENT INJECTABLE$120
- REGENETEN Shoulder$117
How this compares
$15,104 in reported general payments places this provider in the 85th percentile of 44 podiatrist providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 29 | $1,088 |
| Ciclopirox | 17 | $687 |
| Gabapentin | 45 | $636 |
| Lidocaine | 17 | $503 |
| Terbinafine Hcl | 45 | $417 |
| Diclofenac Sodium | 35 | $394 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $169 |
| Oxycodone Hcl | 18 | $100 |
| Silver Sulfadiazine | 12 | $94 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Las Vegas
- Anthony RicciardiLas Vegas$498K
- Jeremy AndersonLas Vegas$72K
- He XuLas Vegas$54K
- Peter BregmanLas Vegas$18K
- Ai Quoc HellerLas Vegas$8K
- John CadeLas Vegas$6K
- Ada VeraLas Vegas$5K
- Michael ChildsLas Vegas$4K
- Justin ColarcoLas Vegas$2K
- Sofia HossainLas Vegas$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.